| Trial ID: | L0497 |
| Source ID: | NCT02480751
|
| Associated Drug: |
Beraprost
|
| Title: |
TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Insufficiency, Chronic
|
| Interventions: |
DRUG: Beraprost|DRUG: Placebo
|
| Outcome Measures: |
Primary: Difference between the run-in and treatment periods in the slope of the regression line of 1/SCr versus time, 50 weeks (Run-in 22weeks, Treatment 28 weeks) |
|
| Sponsor/Collaborators: |
Sponsor: Toray Industries, Inc | Collaborators: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
113
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-10
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2015-06-29
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02480751
|
